VTGN

VistaGen Therapeutics, Inc.

3.71 USD
+0.05 (+1.37%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

VistaGen Therapeutics, Inc. stock is up 15.22% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 30% of the previous 9 July’s closed higher than June.

About VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system. The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in preparation for Phase III development for the acute treatment of anxiety in adults with social anxiety disorder.